Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III Unresectable Non-Small Cell Lung Cancer

NCT07560358 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

204

Enrollment

OTHER

Sponsor class

Conditions

NSCLC (Advanced Non-small Cell Lung Cancer)

Interventions

DRUG: After chemoimmunotherapy induction, followed by concurrent/sequential chemoradiotherapy and subsequent immune consolidation and maintenance therapy.
DRUG: adebrelimab,Radiation Therapy,Radiotherapy

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences